BACKGROUND: The Pasitos Cohort Study has followed children in El Paso, Texas and Ciudad Juarez, Mexico since 1998 to identify determinants of Helicobacter pylori infection. This paper describes patterns of acquisition and elimination of H. pylori infection in 468 children from birth to 24 months. METHODS: Mothers were recruited during pregnancy at maternal-child clinics; children were targeted for follow-up examinations every 6 months after birth. H. pylori infection was detected using the 13C-urea breath test, corrected for age-dependent variation in CO2 production. RESULTS: Test results were available for 359, 341, 269, and 215 children around target ages of 6, 12, 18, and 24 months, respectively. The person-time at risk of a first detectable infection was 7742 person-months; 128 first infections were detected, thus the incidence rate was 1.7% per month (95% confidence interval 1.4-2.0%). Rates were similar in boys and girls and on both sides of the border; evidence suggests, however, that this similarity could be due to selection bias. Among children with follow-up after a positive test, 77% tested negative at a later visit. CONCLUSIONS: The initial acquisition of detectable H. pylori infection occurred at a rate of 20% per year among Pasitos Cohort children from birth to 24 months of age. A key finding, with implications for clinical, community health, and research settings, is that most of these infections did not persist. The transient nature of early H. pylori infection should be considered when designing research or contemplating therapeutic intervention for this age group.
BACKGROUND: The Pasitos Cohort Study has followed children in El Paso, Texas and Ciudad Juarez, Mexico since 1998 to identify determinants of Helicobacter pylori infection. This paper describes patterns of acquisition and elimination of H. pyloriinfection in 468 children from birth to 24 months. METHODS: Mothers were recruited during pregnancy at maternal-child clinics; children were targeted for follow-up examinations every 6 months after birth. H. pyloriinfection was detected using the 13C-urea breath test, corrected for age-dependent variation in CO2 production. RESULTS: Test results were available for 359, 341, 269, and 215 children around target ages of 6, 12, 18, and 24 months, respectively. The person-time at risk of a first detectable infection was 7742 person-months; 128 first infections were detected, thus the incidence rate was 1.7% per month (95% confidence interval 1.4-2.0%). Rates were similar in boys and girls and on both sides of the border; evidence suggests, however, that this similarity could be due to selection bias. Among children with follow-up after a positive test, 77% tested negative at a later visit. CONCLUSIONS: The initial acquisition of detectable H. pyloriinfection occurred at a rate of 20% per year among Pasitos Cohort children from birth to 24 months of age. A key finding, with implications for clinical, community health, and research settings, is that most of these infections did not persist. The transient nature of early H. pyloriinfection should be considered when designing research or contemplating therapeutic intervention for this age group.
Authors: Liviu A Sicinschi; Pelayo Correa; Luis E Bravo; Richard M Peek; Keith T Wilson; John T Loh; Maria C Yepez; Benjamin D Gold; Dexter T Thompson; Timothy L Cover; Barbara G Schneider Journal: Helicobacter Date: 2012-04 Impact factor: 5.753
Authors: Diana T Cervantes; Lori A Fischbach; Karen J Goodman; Carl V Phillips; Shande Chen; Cheryl S Broussard Journal: J Pediatr Gastroenterol Nutr Date: 2010-05 Impact factor: 2.839
Authors: Penny B Travis; Karen J Goodman; Kathleen M O'Rourke; Frank D Groves; Debajyoti Sinha; Joyce S Nicholas; Jim VanDerslice; Daniel Lackland; Kristina D Mena Journal: J Water Health Date: 2010-03 Impact factor: 1.744
Authors: Lucia Pacifico; John Frederick Osborn; Enea Bonci; Sara Romaggioli; Rossella Baldini; Claudio Chiesa Journal: World J Gastroenterol Date: 2014-01-21 Impact factor: 5.742
Authors: Cheryl S Broussard; Karen J Goodman; Carl V Phillips; Mary Ann Smith; Lori A Fischbach; R Sue Day; Corinne C Aragaki Journal: Pharmacoepidemiol Drug Saf Date: 2009-08 Impact factor: 2.890
Authors: Sharon Perry; Maria de la Luz Sanchez; Shufang Yang; Thomas D Haggerty; Philip Hurst; Guillermo Perez-Perez; Julie Parsonnet Journal: Emerg Infect Dis Date: 2006-11 Impact factor: 6.883